Too Many Prescriptions, Too Many Fatal Falls

The phenomenon of taking five or more medicines at the same time has become so common that it now has its own term – polypharmacy – and there is no doubt that it increases the risk of dizziness, confusion, and loss of balance. The post Too Many Prescriptions, Too Many Fatal Falls appeared first on…

Read More

Health Wonk Review

This week’s edition of the Health Wonk Review is up at Joe Paduda’s Managed Care Matters. My article on Singapore’s health care system is highlighted, but check out the whole thing!

Read More

Where Does AgeTech Investment Stand?: VCs Weigh Promise Against Payout

At Medicarians 2025, MedCity News Editor-in-Chief Arundhati Parmar explored the state of AgeTech venture capital with three investors. The panelists agreed that despite growing clear opportunities, the AgeTech market currently lacks the dedicated funding, proven business models and major success stories needed for it to take off. The post Where Does AgeTech Investment Stand?: VCs…

Read More

Medicare Spent an Average of 27% More on People Who Switched from Medicare Advantage to Traditional Medicare Compared to Those Who Were Only in Traditional Medicare

A new KFF analysis finds higher Medicare spending among people who switched from Medicare Advantage to traditional Medicare than for similar beneficiaries who were in traditional Medicare all along. Medicare spent an average of 27% more on such beneficiaries, according to the analysis, which examined health costs in traditional Medicare for both groups in the…More

Read More

Navigating Economic Uncertainty in Biopharma

The biopharmaceutical industry clearly isn’t going anywhere, but we’ve been in a downward business cycle. We’ve learned a lot from the pandemic and have adopted novel approaches to development and this current economic challenge will also inform us. In the meantime, adopting these strategies can de-risk your development programs. The post Navigating Economic Uncertainty in…

Read More